Recurrent chromosomal abnormalities in human embryonic stem cells. - Wikidata - awgldk - TriplyDB

Recurrent chromosomal abnormalities in human embryonic stem cells.

Recurrent chromosomal abnormalities in human embryonic stem cells.

http://www.wikidata.org/entity/Q39912737

about

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells Changing Paradigms in Cranio-Facial Regeneration: Current and New Strategies for the Activation of Endogenous Stem Cells Stem cell application for osteoarthritis in the knee joint: A minireview Aneuploidy in pluripotent stem cells and implications for cancerous transformation Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny The landscape of somatic copy-number alteration across human cancers.Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels Chromosome 7 and 19 trisomy in cultured human neural progenitor cells.Pluripotency genes overexpressed in primate embryonic stem cells are localized on homologues of human chromosomes 16, 17, 19, and X Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.LPA-primed astrocytes induce axonal outgrowth of cortical progenitors by activating PKA signaling pathways and modulating extracellular matrix proteins Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts Lessons from human teratomas to guide development of safe stem cell therapies.Genetic and epigenetic instability in human pluripotent stem cells.Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells Pluripotency and its layers of complexity.Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations Derivation of two new human embryonic stem cell lines from nonviable human embryos.The essential role of evasion from cell death in cancer.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium Genomic instability of human embryonic stem cell lines using different passaging culture methods.Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.Human pluripotent stem cells: applications and challenges in neurological diseases.Human embryonic stem cell responses to ionizing radiation exposures: current state of knowledge and future challenges Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.Non-colony type monolayer culture of human embryonic stem cells.Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q.High-throughput karyotyping of human pluripotent stem cells.Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability.Aneuploid cells are differentially susceptible to caspase-mediated death during embryonic cerebral cortical development.Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations.

P2860

Q24634829-E6184F38-E0A8-44FE-BE93-DBAEF30A588C Q26768579-7381BA5B-4954-49D6-92E4-B77909F6303F Q26827246-E7D75DC1-19B2-4B5C-8016-2F78837C7657 Q27013982-6C2C4ACC-0FD7-4089-8F0E-E99C4CFAC15F Q27317676-3DE5EEF0-F06A-4ECC-89C3-A472D3E3B137 Q29547648-38889490-15EC-45C7-888A-9F81494A0552 Q30391597-892DDA91-BE45-4C7C-BB99-189F00851607 Q30541092-FC83F412-5EF5-47D1-A2BD-6911227CB514 Q33515583-01047D65-BF74-4943-A422-7548D51F8274 Q33636608-3045A700-8445-47B9-880F-477CEF19B9F1 Q33648633-629BC4AF-D871-4615-9F23-E1996E218D42 Q33999117-BD354471-7095-4594-80E1-B2CDC43E31F2 Q34038185-CABA1F72-B167-4A6C-93CB-9594A86CF7F4 Q34242029-CFC7FE81-5234-49EF-9ED5-FBD190A2B826 Q34294018-82A0ABD5-BB36-4CD4-B41B-6D60F5041B34 Q34298868-2E14B377-D368-4F0E-BB87-37078C6112AF Q34316491-8A2CCDEA-B113-45E3-B34F-D34B588AADEC Q34333314-E45F1087-20DB-41A9-85D1-324670ED8699 Q34503625-99BDAC1C-EB1C-425D-ABD7-C4AA83A1ECB4 Q34596358-4BD84711-B137-4245-B56D-DEA79F4A0391 Q34800989-147953BF-11DF-4908-9E63-C469B15D73BC Q35054489-91A5638E-D397-4443-8F8D-F7190532D693 Q35083049-864A08C3-2CA0-4114-BB71-8AA001B3D8C0 Q35648168-AC7FF9B7-696B-438D-BF31-093DB280F9BD Q35653080-BA6A622D-A3BF-4F25-AD7B-B0F4CBC81264 Q35686581-CBD37500-18AF-4371-88BF-20228C8ADA29 Q35966957-F7068D03-0B73-420E-86EB-BBB8C11923E6 Q36193696-855032E4-D867-4AE9-8779-655676765818 Q36200201-CBE5B4C4-4C30-4F55-971A-3E3B607783E5 Q36266493-8B3DCFA2-B486-40A6-B3B8-02148E36C5D9 Q36321047-F353F298-5CBC-4C24-80EC-B516EA517B9C Q36374337-EC2F00AA-49D6-4046-B48E-81593DFC52EE Q36403953-A7D73D6E-D4FB-4C39-B697-FD6A7EF1063C Q36413729-1D855833-DFB9-4733-BF80-A540598E3783 Q36673714-9F068B5C-8D18-404C-93B6-E9700291F93E Q36678840-18FB7B3E-C5B0-4BD4-8838-88B493805CEA Q36734923-7E853274-C799-4E0D-9623-4F9EC374BE32 Q36934047-0E9A1EA5-E0D0-4762-8A55-0105204D31EE Q36985112-612BA555-B497-4AAB-8CA9-BF745C2B480A Q37194068-39FCF887-5200-4011-B276-67614ED93C1E

P2860

Recurrent chromosomal abnormalities in human embryonic stem cells.

http://www.wikidata.org/entity/Q39912737

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Recurrent chromosomal abnormalities in human embryonic stem cells.

@en

Recurrent chromosomal abnormalities in human embryonic stem cells.

@nl

type

label

Recurrent chromosomal abnormalities in human embryonic stem cells.

@en

Recurrent chromosomal abnormalities in human embryonic stem cells.

@nl

prefLabel

Recurrent chromosomal abnormalities in human embryonic stem cells.

@en

Recurrent chromosomal abnormalities in human embryonic stem cells.

@nl

P1433

Q39912737-B87BF510-966F-4FE8-A4CC-76C1630EC91C

P1476

Q39912737-B470BBB0-4894-494C-A5CE-F268701DBA9E

P2093

Q39912737-0846E085-72EC-4DA5-A0F1-D6905139834A

Q39912737-25E43158-94BD-445A-9D8D-9F6FE1C8C470

Q39912737-389F3B0E-75F3-4088-B863-E6CF643FA768

Q39912737-477BE3F2-B826-415F-8E53-438079E2A40E

Q39912737-765D3303-1342-4093-9EBB-4E7E9531FCDC

Q39912737-823B343E-4D55-4E7F-B48B-0F6EF20667F0

Q39912737-B0C4DFD4-91CC-4010-B791-87AED5C286B5

Q39912737-B86BD8F8-7D3B-48F3-95D4-F55DB81A7C74

Q39912737-DD1930CD-B5F3-44D7-9D1C-7AF2E00B35BC

P2860

Q39912737-0964AFAF-5EDD-4869-90C2-D6189B033F88

Q39912737-27552A66-1D4F-4521-AE8C-265BC1737495

Q39912737-2C16C7F6-9793-4789-A82B-5FC5A5E71C98

Q39912737-30C2AFBB-ADA2-479E-9E98-D27EC173A3D2

Q39912737-31DB5CFC-7322-4B97-A703-EF8753A57B20

Q39912737-677DEED0-7B61-4A08-BD23-9FA83B3C1566

Q39912737-6A4E279C-B137-4B3D-BAED-96E5BBCF5490

Q39912737-A0801494-9284-4E10-AB56-3B3FE684C7B7

Q39912737-A51CACAD-B93B-4B26-BF61-18BDA46CA980

Q39912737-AD58E151-A26B-494F-8FA5-CB7270BA4A81

P2888

Q39912737-F6F741AF-1B17-4970-A519-F759063A76C9

P304

Q39912737-5D3FEBFC-7A5E-4F82-94A6-6266A98F7F16

P31

Q39912737-A00D9470-7F30-4726-868C-6B249C38976D

P356

Q39912737-94B200A3-3C5D-4E65-B267-4DF16134BFEC

P433

Q39912737-18C3CED2-A020-408B-8E00-0939A0D87E9C

P478

Q39912737-D1FBDEA4-9ABB-4994-9276-A60498FA9D88

P577

Q39912737-D1D59F12-3822-4F03-9DCC-7D71418174FD

P698

Q39912737-A3FE2C2D-3ABA-4000-BB7B-39A3CD6A889F

P356

P1433

Nature Biotechnology

P1476

Recurrent chromosomal abnormalities in human embryonic stem cells.

@en

P2093

Afroditi Mertzanidou

http://www.w3.org/2001/XMLSchema#string

Catherine Staessen

http://www.w3.org/2001/XMLSchema#string

Claudia Spits

http://www.w3.org/2001/XMLSchema#string

Ileana Mateizel

http://www.w3.org/2001/XMLSchema#string

Inge Liebaers

http://www.w3.org/2001/XMLSchema#string

Josiane Van der Elst

http://www.w3.org/2001/XMLSchema#string

Karen Sermon

http://www.w3.org/2001/XMLSchema#string

Mieke Geens

http://www.w3.org/2001/XMLSchema#string

Yves Vandeskelde

http://www.w3.org/2001/XMLSchema#string

P2860

Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q

Human chromosome fragility

Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations.

Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome

Molecular cytogenetics: making it safe for human embryonic stem cells to enter the clinic.

Copy number variant analysis of human embryonic stem cells.

CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells.

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

Genomic alterations in cultured human embryonic stem cells.

Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation.

P2888

P304

1361-1363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.1510

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19029912

http://www.w3.org/2001/XMLSchema#string